Negotiations between MSD and Revolution Medicines over a possible takeover – estimated to have been potentially worth up to $30 billion – have reportedly ended without agreement. That is according to ...
The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results